UNICYCIVE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.03 USD | +6.19% |
|
-3.74% | +18.70% |
Chart calendar Unicycive Therapeutics, Inc.
4fb7a6dbc1fd11b2507438c17.-K92M4fGa9OWq_P7H2nr01-qV1O1BdsJNBEGLrZunO8.t8wBRNL_OIXB3MHCXQ66lC_GICDmZusxTn1yHfVY0JzK-gJQ4a4_i-bpkA~e0c896c2a944daa0d4e698dfac1118c0
Upcoming events on Unicycive Therapeutics, Inc.
Past events on Unicycive Therapeutics, Inc.
| 2024-04-18 11:00 am | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 2024-03-28 04:15 pm | Q4 2023 Earnings Release |
| 2024-03-12 08:30 pm | International Conference on Advances in Critical Care Nephrology AKI and CRRT - UNI-494 Poster Prese |
| 2024-03-12 08:30 pm | International Conference on Advances in Critical Care Nephrology AKI and CRRT - UNI-494 Oral Present |
| 2023-12-06 | Benchmark Company Discovery Conference - One-on-one |
| 2023-12-04 03:30 pm | Noble Capital Markets Emerging Growth Equity Conference |
| 2023-11-14 04:15 pm | Q3 2023 Earnings Release |
| 2023-08-14 05:36 pm | Q2 2023 Earnings Release |
| 2023-07-25 11:00 am | H.C. Wainwright Kidney Conference |
| 2023-06-26 12:00 pm | Annual General Meeting |
| 2023-06-20 09:00 am | Maxim Group Virtual Healthcare Conference |
| 2023-06-14 | European Renal Association Congress - Shalabh Gupta |
| 2023-05-16 08:29 am | Q1 2023 Earnings Release |
| 2023-04-10 | National Kidney Foundation Spring Clinical Meeting |
| 2023-03-31 | Critical Care in Nephrology International Conference - UNI-494 is well-tolerated in dogs |
| 2023-03-31 07:00 am | Q4 2022 Earnings Release |
| 2023-03-29 | International Society of Nephrology World Congress |
| 2023-03-28 | Critical Care in Nephrology International Conference - UNI-494 Lowers Urine 2-microglobulin in Rats |
| 2023-03-07 12:00 pm | Chronic Kidney Disease Drug Development Summit |
| 2023-02-02 10:00 am | Sequire Biotechnology Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,95 0,96 -1.02% | 0,68 0,37 83.05% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -8,98 -8,76 -2.45% | -18,1 -16,6 -8.77% | -20,8 -20,0 -3.7% | -26,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,0 -9,99 -0.32% | -18,1 -16,7 -8.21% | -30,5 -28,7 -6.32% | -25,8 |
|
Net income Million USD | Released Forecast Spread | -2,26 | -10,0 -9,64 -3.86% | -18,1 -16,6 -8.88% | -31,4 -29,6 -6.08% | -25,8 |
|
EPS USD | Released Forecast Spread | -0,26 | -0,86 -0,50 -72% | -1,20 -1,09 -10.09% | -1,28 -1,24 -3.5% | -0,55 |
| Announcement Date | 18/02/21 | 31/03/22 | 31/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,95 0,00 - | 0,00 0,00 - | 0,68 0,38 80% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -2,75 -2,05 -34.24% | -3,54 -2,45 -44.37% | -3,64 -3,41 -6.71% | -5,55 -4,23 -31.45% | -5,33 -3,88 -37.4% | -4,20 -5,70 26.25% | -4,32 -6,33 31.76% | -5,94 -4,60 -29.09% | -6,31 -5,37 -17.63% | -6,26 | -6,46 | -6,54 | -6,82 | -6,41 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,75 -1,70 -61.88% | -3,54 -1,90 -86.16% | -3,64 -3,41 -6.63% | -5,56 -4,53 -22.81% | -5,33 -3,97 -34.3% | -14,6 -5,63 -158.79% | -3,84 -6,31 39.13% | -4,33 -4,61 6.01% | -7,80 -6,01 -29.86% | -6,28 | -6,48 | -6,39 | -6,67 | -6,41 |
|
Net income Million USD | Released Forecast Spread | -2,75 -2,08 -32.31% | -3,54 -2,77 -27.77% | -3,64 -3,45 -5.54% | -5,56 -4,28 -29.98% | -5,33 -3,86 -37.99% | -14,8 -5,72 -157.98% | -4,44 -6,61 32.76% | -4,41 -4,61 4.45% | -8,67 -6,01 -44.3% | -6,28 | -6,48 | -6,39 | -6,67 | -6,41 |
|
EPS USD | Released Forecast Spread | -0,17 -0,14 -25.93% | -0,24 -0,19 -26.32% | -0,24 -0,23 -5.49% | -0,37 -0,28 -32.14% | -0,35 -0,24 -43.44% | -0,97 -0,37 -160.4% | -0,29 -0,44 33.33% | -0,13 -0,13 0% | -0,16 -0,18 11.11% | -0,16 | -0,13 | -0,12 | -0,11 | -0,10 |
| Announcement Date | 31/03/22 | 12/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 16/05/23 | 14/08/23 | 14/11/23 | 28/03/24 | - | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Unicycive Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- UNCY Stock
- Calendar Unicycive Therapeutics, Inc.
